If you really love your dog and have about $150,000 to spare, you can now order a clone from Korean biotechnology company RNL Bio. Geneticists revealed earlier today that they have created the first dogs cloned for commercial purposes: five puppies created with DNA from Booger the pit bull terrier. (Dogs have previously been cloned for scientific and government purposes.)
According to the Guardian,
“The five clones cost Bernann McKinney, a Californian-based farmer, £25,000 ($50,000) and were well worth it, she said at a press conference in the South Korean capital, Seoul, where the announcement was made.
“… When Booger got cancer, McKinney had skin cells taken from the dog and preserved in the hope that science would come to her aid. Scientists at Seoul National University used the cells to create embryos, which where [sic] then implanted into two surrogate mother dogs. The puppies were born on July 28.”
RNL Bio, which produced seven clones of Toppie, a drug-sniffing dog, in 2006, and four clones of a cancer-sniffing dog from Japan named Marine in 2007, says that it is also interested in cloning camels for customers in the Middle East.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.